Proven to improve glycemic control and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 1 BURNABY, BC , May 26, 2021 /CNW Telbec/ - Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), announced today that

SAN DIEGO --(BUSINESS WIRE)--Apr. 29, 2021-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2021 . First Quarter 2021 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $505.0 million U.S.

Dexcom G6 gives people with diabetes the power to manage their condition without fingersticks* or scanning Proven to improve glycemic control and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring 1 BURNABY, BC , April 20, 2021 /CNW/ - Dexcom

Dexcom G6 gives people with diabetes the power to manage their condition without fingersticks* or scanning BURNABY, BC , April 16, 2021 /CNW/ - Dexcom , Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), is pleased to see that the governments of Saskatchewan and

Dexcom is now directly selling the Dexcom G6 Continuous Glucose Monitoring (CGM) System across the Netherlands Dexcom G6 CGM means no more fingersticks * for people with diabetes Real-time glucose data sent wirelessly to a compatible smart device † or Dexcom receiver Customisable alerts and alarms

SAN DIEGO --(BUSINESS WIRE)--Apr. 1, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2021 financial results after market close on Thursday, April 29, 2021 . Management will hold a conference call to review the company's first quarter 2021 performance

SAN DIEGO --(BUSINESS WIRE)--Mar. 23, 2021-- DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the promotion of Jereme Sylvain to the role of Executive Vice President and Chief Financial Officer. In his expanded role, Mr.

SAN DIEGO --(BUSINESS WIRE)--Feb. 17, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming virtual investor conferences: Quentin Blackford , Chief Operating Officer and Chief Financial Officer, will present on behalf of

Dexcom Ventures to identify and invest in transformational technologies to advance long-term growth SAN DIEGO --(BUSINESS WIRE)--Feb. 11, 2021-- DexCom, Inc. (Nasdaq: DXCM), the global leader in continuous glucose monitoring for people with diabetes, today announced the launch of Dexcom Ventures .

SAN DIEGO --(BUSINESS WIRE)--Feb. 11, 2021-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2020 . Fourth Quarter 2020 Financial Highlights: Revenue grew 23% versus the same quarter of the prior year to $568.9 million